REQUEST A DEMO
Total
USD $0.00
Search more companies

Green Cross Cell Corporation (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Green Cross Cell Corporation Profile Updated: July 01, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Green Cross Cell Corporation is engaged in manufacturing of anti-cancer drugs. The company operates in three business areas: Immunotherapy is engaged in developing and manufacturing anti-cancer drugs for liver cancer, brain tumor, pancreatic cancer, among others; Cord Blood Cryopreservation is engaged in cryopreservation of cord blood found in the placenta and umbilical cord which in turn used to treat incurable diseases such as childhood cancer, leukemia, and other diseases; and KGMP service is engaged in providing hi-tech production facilities used to manufacture pharmaceutical products. Green Cross Cell Corporation distributes Immuncell-LC drugs. The company is based in Seoul, South Korea. Green Cross Cell Corporation was incorporated in 1992.

Headquarters
107, Ihyeon-ro 30beon-gil Giheung-gu Yongin-si Gyeonggi
Yongin; Gyeonggi; Postal Code: 153769

Contact Details: Purchase the Green Cross Cell Corporation report to view the information.

Website: http://www.greencrosscell.com/

Basic Information
Total Employees:
Purchase the Green Cross Cell Corporation report to view the information.
Outstanding Shares:
Purchase the Green Cross Cell Corporation report to view the information.
Registered Capital:
Purchase the Green Cross Cell Corporation report to view the information.
Financial Auditors:
Purchase the Green Cross Cell Corporation report to view the information.
Incorporation Date:
September 17, 1992
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Senior Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
24.5%
Purchase this report to view the information.
4.9%
Subsidiaries
Seoul C&I
100%
Seoul Technology
100%
Book Mark
40.6%
Company Performance
Financial values in the chart are available after Green Cross Cell Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
27.66%
Total operating revenue
27.66%
Operating profit (EBIT)
36.96%
EBITDA
34.92%
Net Profit (Loss) for the Period
-21.51%
Total assets
22.33%
Total equity
25.61%
Operating Profit Margin (ROS)
1.02%
Net Profit Margin
-18.82%
Return on Equity (ROE)
-7.68%
Debt to Equity Ratio
-49.52%
Quick Ratio
-5.99%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?